QQQ $ 606.81 $ 1.61 (0.27 %)
DIA $ 464.07 $ 0.68 (0.15 %)
SPY $ 667.76 $ 0.87 (0.13 %)
TLT $ 90.67 $ 0.17 (0.19 %)
GLD $ 393.00 $ 1.85 (0.47 %)
$ 0.005
-- x --
-- x --
-- - --
$ 0.00 - $ 3.40
29,688
na
134,162
$ -8.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2024 09-30-2024 10-Q
2 07-31-2024 06-30-2024 10-Q
3 05-14-2024 03-31-2024 10-Q
4 03-27-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-08-2023 06-30-2023 10-Q
7 05-10-2023 03-31-2023 10-Q
8 03-02-2023 12-31-2022 10-K
9 11-14-2022 09-30-2022 10-Q
10 08-09-2022 06-30-2022 10-Q
11 05-16-2022 03-31-2022 10-Q
12 03-15-2022 12-31-2021 10-K
13 11-05-2021 09-30-2021 10-Q
14 08-05-2021 06-30-2021 10-Q
15 05-06-2021 03-31-2021 10-Q
16 03-04-2021 12-31-2020 10-K
17 11-05-2020 09-30-2020 10-Q
18 08-06-2020 06-30-2020 10-Q
19 05-07-2020 03-31-2020 10-Q
20 03-05-2020 12-31-2019 10-K
21 11-12-2019 09-30-2019 10-Q
22 08-01-2019 06-30-2019 10-Q
23 05-01-2019 03-31-2019 10-Q
24 03-07-2019 12-31-2018 10-K
25 11-01-2018 09-30-2018 10-Q
26 08-07-2018 06-30-2018 10-Q
27 05-10-2018 03-31-2018 10-Q
28 03-12-2018 12-31-2017 10-K
29 11-08-2017 09-30-2017 10-Q
30 08-09-2017 06-30-2017 10-Q
31 05-15-2017 03-31-2017 10-Q
32 03-20-2017 12-31-2016 10-K
33 11-14-2016 09-30-2016 10-Q
34 08-15-2016 06-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 us-stocks-likely-to-open-higher-as-wall-street-watches-trump-tariff-talks-march-april-may-tend-to-be-solid-months-in-post-election-years-says-expert

US. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark indices rose in premarket tra...

 syros-announces-voluntary-delisting-from-nasdaq-and-sec-deregistration-delisting-is-expected-to-become-effective-on-or-about-march-20-2025

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the "Company") today announced that its Board of Directors (the "Board&#...

Core News & Articles

On November 13, 2024, Syros Pharmaceuticals, Inc. (the "Company") gave notice to QIAGEN Manchester Limited ("QIAGEN...

 syros-pharmaceuticals-stock-sinks-as-pivotal-blood-cancer-trial-flunks-triggers-loan-default

Syros Pharmaceuticals' Phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome did not meet primary endpoints...

 td-cowen-downgrades-syros-pharmaceuticals-to-hold

TD Cowen analyst Phil Nadeau downgrades Syros Pharmaceuticals (NASDAQ:SYRS) from Buy to Hold.

 hc-wainwright--co-downgrades-syros-pharmaceuticals-to-neutral-lowers-price-target-to-1

HC Wainwright & Co. analyst Andrew Fein downgrades Syros Pharmaceuticals (NASDAQ:SYRS) from Buy to Neutral and lowers th...

 jmp-securities-downgrades-syros-pharmaceuticals-to-market-perform

JMP Securities analyst Jason Butler downgrades Syros Pharmaceuticals (NASDAQ:SYRS) from Market Outperform to Market Perform.

 brookline-capital-downgrades-syros-pharmaceuticals-to-hold

Brookline Capital analyst Leah Rush downgrades Syros Pharmaceuticals (NASDAQ:SYRS) from Buy to Hold.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION